Skip to content

Registry for Acute Decompensated Heart Failure Patients

ADHERE Core III - Acute Decompensated Heart Failure Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00366639
Enrollment
24118
Registered
2006-08-21
Start date
2001-10-31
Completion date
2006-02-28
Last updated
2009-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Decompensation, Heart Failure, Congestive

Keywords

Heart failure, congestive, Heart decompensation

Brief summary

The purpose of the ADHERE study is to develop a multi-center, observational, open-label registry of the management strategies of patients treated in the hospital for acute Heart Failure in the United States.

Detailed description

The objective is to compile a clinical database on the strategy for the medical management of patients hospitalized with acute Heart Failure (HF). Through the use of the information collected from acute care hospitals across the United States the following information may be coming out of this study: 1) Assist hospitals in evaluating and improving quality of care for patients with acute HF by tracking quality indicators and providing benchmark data reports; 2) Describe the demographic and clinical characteristics of patients who are hospitalized with acute HF; 3) Characterize the initial emergency department evaluation and subsequent inpatient management of patients hospitalized with acute HF; 4) Identify patient characteristics and medical care practices associated with improved health outcomes in those hospitalized with acute HF; 5) Characterize trends and changes over time in the management of acute HF; 6) Offer surveillance of adherence to practice guidelines as these emerge for the inpatient management of acute HF. Observational Study - No investigational drug administered

Interventions

OTHERAcute Decompensated Heart Failure

Treatment & outcomes during hospital admission for Acute DHF

Sponsors

Scios, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than or equal to 18 years at the time of admission to the hospital * Received or is eligible to receive a principal hospital discharge diagnosis of HF * Decompensated HF is present as determined clinically by the patient care team

Exclusion criteria

* HF is present as a co-morbid condition, but is not a principal focus of diagnosis or treatment during this hospitalization episode

Design outcomes

Primary

MeasureTime frame
Course of care in the Emergency Department (ED) and course of care in the inpatient hospital, use of diuretics (increase urine excretion) vasodilators (relax artey and veins) and inotropeic agents (increase the function of the heart) rate of deathFrom admission to discharge from the hospital

Secondary

MeasureTime frame
Data from patient demographics ( sex, age, gender, race)at patients admission

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026